Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

LSTA

Lisata Therapeutics Inc

May 12 • 04:00PM ET

3.26

0.00 0.00 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: CUE BLRX SABS TNXP PALI

| Held by: VTI VXF DFSU DCOR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.86	Insider Own	18.83%	Shs Outstand	9.11M	Perf Week	-0.31%
Market Cap	29.69M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	7.39M	Perf Month	-34.67%
Enterprise Value	16.38M	PEG	-	EPS next Q	-	Inst Own	8.15%	Short Float	0.95%	Perf Quarter	-28.19%
Income	-16.35M	P/S	174.65	EPS this Y	-	Inst Trans	-1.20%	Short Ratio	0.93	Perf Half Y	58.25%
Sales	0.17M	P/B	2.72	EPS next Y	-	ROA	-75.98%	Short Interest	0.07M	Perf YTD	75.27%
Book/sh	1.20	P/C	2.27	EPS next 5Y	-	ROE	-90.13%	52W High	5.07 -35.70%	Perf Year	46.53%
Cash/sh	1.43	P/FCF	-	EPS past 3/5Y	43.29% 24.76%	ROIC	-149.65%	52W Low	1.81 80.11%	Perf 3Y	-1.21%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	38.24%	Volatility	4.77% 8.37%	Perf 5Y	-84.80%
Dividend TTM	-	EV/Sales	96.35	EPS Y/Y TTM	19.02%	Oper. Margin	-10178.24%	ATR (14)	0.19	Perf 10Y	-96.44%
Dividend Ex-Date	-	Quick Ratio	4.23	Sales Y/Y TTM	-83.00%	Profit Margin	-9618.24%	RSI (14)	37.39	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.23	EPS Q/Q	9.25%	SMA20	0.09%	Beta	0.81	Target Price	4.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-23.15%	Rel Volume	0.24	Prev Close	3.26
Employees	21	LT Debt/Eq	0.00	Earnings	Nov 06 AMC	SMA200	5.77%	Avg Volume	75.57K	Price	3.26
IPO	Nov 03, 1995	Option/Short	No / Yes	EPS/Sales Surpr.	8.41% -	Trades		Volume	18,016	Change	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)